Search for Anti-EA(D) Antibodies in Subjects with an "Isolated VCA IgG" Pattern
- PMID: 20652034
- PMCID: PMC2905898
- DOI: 10.1155/2010/695104
Search for Anti-EA(D) Antibodies in Subjects with an "Isolated VCA IgG" Pattern
Abstract
The presence of an "isolated viral capsid antigen (VCA) IgG" pattern in serum is not easy to interpret without the aid of further tests, such as specific immunoblotting or a virus genome search, that often give rise to organisational and economic problems. However, one alternative is to use an enzyme-linked immunosorbent assay (ELISA) to detect anti-early antigen (EA) antibodies, which can be found in about 85% of subjects with acute Epstein-Barr virus (EBV) infections. The purpose of this work was to search for anti-EA(D) antibodies in 130 samples with an isolated VCA IgG pattern at ELISA screening and classified as being indicative of past (102 cases) or acute (28 cases) infection on the basis of the immunoblotting results. Thirty-seven samples (28.5%) were positive for anti-EA(D), of which 25 (89.3%) had been classified by immunoblotting as indicating acute and 12 (11.8%) past EBV infection. This difference was statistically significant (P < .01). The results of our search for anti-EA(D) antibodies correctly identified nearly 90% of acute (presence) or past EBV infections (absence). When other tests are not available, the search for anti-EA antibodies may therefore be helpful in diagnosing patients with an isolated VCA IgG pattern at screening tests.
Similar articles
-
Serological diagnosis of Epstein-Barr virus infection: Problems and solutions.World J Virol. 2012 Feb 12;1(1):31-43. doi: 10.5501/wjv.v1.i1.31. World J Virol. 2012. PMID: 24175209 Free PMC article. Review.
-
Anti-Epstein-Barr virus antibodies in Beijing during 2013-2017: What we have found in the different patients.PLoS One. 2018 Mar 1;13(3):e0193171. doi: 10.1371/journal.pone.0193171. eCollection 2018. PLoS One. 2018. PMID: 29494658 Free PMC article.
-
Expression of Epstein-Barr virus antibodies EA-IgG, Rta-IgG, and VCA-IgA in nasopharyngeal carcinoma and their use in a combined diagnostic assay.Genet Mol Res. 2016 Mar 18;15(1). doi: 10.4238/gmr.15017368. Genet Mol Res. 2016. PMID: 27050964
-
Comparison of Epstein-Barr Virus Serological Tools for the Screening and Risk Assessment of Nasopharyngeal Carcinoma: a Large Population-based Study.Pathol Oncol Res. 2020 Oct;26(4):2185-2190. doi: 10.1007/s12253-020-00808-0. Epub 2020 Mar 28. Pathol Oncol Res. 2020. PMID: 32222897
-
Serological Evidence for the Association Between Epstein-Barr Virus Infection and Sjögren's Syndrome.Front Immunol. 2020 Oct 30;11:590444. doi: 10.3389/fimmu.2020.590444. eCollection 2020. Front Immunol. 2020. PMID: 33193425 Free PMC article.
Cited by
-
Performance of two commercially available automated immunoassays for the determination of Epstein-Barr virus serological status.Clin Vaccine Immunol. 2012 Jun;19(6):929-34. doi: 10.1128/CVI.00100-12. Epub 2012 Apr 25. Clin Vaccine Immunol. 2012. PMID: 22539474 Free PMC article.
-
Serological diagnosis of Epstein-Barr virus infection: Problems and solutions.World J Virol. 2012 Feb 12;1(1):31-43. doi: 10.5501/wjv.v1.i1.31. World J Virol. 2012. PMID: 24175209 Free PMC article. Review.
-
Antibodies to early EBV, CMV, and HHV6 antigens in systemic lupus erythematosus patients.Scand J Rheumatol. 2015;44(2):143-9. doi: 10.3109/03009742.2014.973061. Epub 2015 Jan 6. Scand J Rheumatol. 2015. PMID: 25562120 Free PMC article.
-
EBV reactivation serological profile in primary Sjögren's syndrome: an underlying trigger of active articular involvement?Rheumatol Int. 2013 May;33(5):1149-57. doi: 10.1007/s00296-012-2504-3. Epub 2012 Sep 6. Rheumatol Int. 2013. PMID: 22955798
References
-
- Macsween KF, Crawford DH. Epstein-Barr virus—recent advances. Lancet Infectious Diseases. 2003;3(3):131–140. - PubMed
-
- de Paschale M, Agrappi C, Manco MT, Mirri P, Viganò EF, Clerici P. Seroepidemiology of EBV and interpretation of the "isolated VCA IgG" pattern. Journal of Medical Virology. 2009;81(2):325–331. - PubMed
-
- Bauer G. The rational basis for efficient Epstein-Barr virus (EBV) serology. Clinical Laboratory. 1995;41(9):623–634.
LinkOut - more resources
Full Text Sources
Miscellaneous